Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new mutation causing familial amyloidotic polyneuropathy.

J C Skare1, M J Saraiva, I L Alves

  • 1Center for Human Genetics, Boston University School of Medicine, MA.

Biochemical and Biophysical Research Communications
|November 15, 1989
PubMed
Summary

Researchers identified a new transthyretin gene mutation in a familial amyloidotic polyneuropathy patient. This novel mutation, located in exon 3, causes altered transthyretin properties and may lead to amino acid changes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel intragenic deletion in OPHN1 in a family causing XLMR with cerebellar hypoplasia and distinctive facial appearance.

Clinical genetics·2010
Same author

Pallister-Killian syndrome: tetrasomy of 12pter-->12p11.22 in a boy with an analphoid, inverted duplicated marker chromosome.

Clinical genetics·2007
Same author

The value of MLPA in Waardenburg syndrome.

Genetic testing·2007
Same author

The prenatal diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) by mutation analysis.

Prenatal diagnosis·2005
Same author

Characterization of an analphoid supernumerary marker chromosome derived from 15q25-->qter using high-resolution CGH and multiplex FISH analyses.

Clinical genetics·2005
Same author

Molecular cytogenetic characterization of multiple intrachromosomal rearrangements of chromosome 2q in a patient with Waardenburg's syndrome and other congenital defects.

Clinical genetics·2004

Area of Science:

  • Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • Familial amyloidotic polyneuropathy (FAP) is a hereditary disease.
  • Previous research linked FAP to specific mutations in the transthyretin (TTR) gene.

Observation:

  • DNA analysis of an FAP patient revealed no known TTR gene mutations.
  • A novel 7.0 kb Sph I restriction fragment was detected in the patient's DNA.

Findings:

  • The identified mutation is located in exon 3 of the transthyretin gene.
  • This mutation is heritable and may cause amino acid substitutions (glu89, his90, or ala91).
  • The patient's transthyretin exhibits a lower isoelectric point (pI) compared to normal.

Implications:

Related Experiment Videos

  • This discovery expands the known genetic basis of familial amyloidotic polyneuropathy.
  • Understanding novel mutations aids in diagnosing and potentially treating FAP.
  • Altered transthyretin properties may be key to disease pathogenesis.